NIIT Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 28, 2025, 8:56 am

Competitors of NIIT Ltd

All Competitor Stocks of NIIT Ltd

Quarterly Result

Last Updated: May 31, 2025, 8:17 am

Below is a detailed analysis of the quarterly data for NIIT Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 86.00 Cr.. The value appears to be declining and may need further review. It has decreased from 98.00 Cr. (Dec 2024) to 86.00 Cr., marking a decrease of 12.00 Cr..
• For Expenses, as of Mar 2025, the value is 88.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 91.00 Cr. (Dec 2024) to 88.00 Cr., marking a decrease of 3.00 Cr..
• For Operating Profit, as of Mar 2025, the value is -1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7.00 Cr. (Dec 2024) to -1.00 Cr., marking a decrease of 8.00 Cr..
• For OPM %, as of Mar 2025, the value is -2.00%. The value appears to be declining and may need further review. It has decreased from 7.00% (Dec 2024) to -2.00%, marking a decrease of 9.00%.
• For Other Income, as of Mar 2025, the value is 24.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Dec 2024) to 24.00 Cr., marking an increase of 7.00 Cr..
• For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
• For Depreciation, as of Mar 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 6.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 17.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 17.00 Cr..
• For Tax %, as of Mar 2025, the value is 17.00%. The value appears to be improving (decreasing) as expected. It has decreased from 19.00% (Dec 2024) to 17.00%, marking a decrease of 2.00%.
• For Net Profit, as of Mar 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 14.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 0.97. The value appears to be declining and may need further review. It has decreased from 0.99 (Dec 2024) to 0.97, marking a decrease of 0.02.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 4:47 am

Growth

Last Updated: September 5, 2025, 11:40 am

Balance Sheet

Last Updated: November 9, 2025, 2:36 pm

Below is a detailed analysis of the balance sheet data for NIIT Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 27.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 27.00 Cr..
• For Reserves, as of Sep 2025, the value is 1,043.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,052.00 Cr. (Mar 2025) to 1,043.00 Cr., marking a decrease of 9.00 Cr..
• For Borrowings, as of Sep 2025, the value is 7.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 6.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 1.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 172.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 118.00 Cr. (Mar 2025) to 172.00 Cr., marking an increase of 54.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 1,249.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,204.00 Cr. (Mar 2025) to 1,249.00 Cr., marking an increase of 45.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 370.00 Cr.. The value appears strong and on an upward trend. It has increased from 258.00 Cr. (Mar 2025) to 370.00 Cr., marking an increase of 112.00 Cr..
• For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 32.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 32.00 Cr..
• For Investments, as of Sep 2025, the value is 616.00 Cr.. The value appears to be declining and may need further review. It has decreased from 678.00 Cr. (Mar 2025) to 616.00 Cr., marking a decrease of 62.00 Cr..
• For Other Assets, as of Sep 2025, the value is 262.00 Cr.. The value appears strong and on an upward trend. It has increased from 236.00 Cr. (Mar 2025) to 262.00 Cr., marking an increase of 26.00 Cr..
• For Total Assets, as of Sep 2025, the value is 1,249.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,204.00 Cr. (Mar 2025) to 1,249.00 Cr., marking an increase of 45.00 Cr..

Notably, the Reserves (1,043.00 Cr.) exceed the Borrowings (7.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for NIIT Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 3.41. This value is below the healthy minimum of 5. It has increased from 2.85 (Mar 24) to 3.41, marking an increase of 0.56.
• For Diluted EPS (Rs.), as of Mar 25, the value is 3.36. This value is below the healthy minimum of 5. It has increased from 2.81 (Mar 24) to 3.36, marking an increase of 0.55.
• For Cash EPS (Rs.), as of Mar 25, the value is 5.26. This value is within the healthy range. It has increased from 4.28 (Mar 24) to 5.26, marking an increase of 0.98.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 79.57. It has increased from 76.92 (Mar 24) to 79.57, marking an increase of 2.65.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 79.57. It has increased from 76.92 (Mar 24) to 79.57, marking an increase of 2.65.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 26.37. It has increased from 22.47 (Mar 24) to 26.37, marking an increase of 3.90.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 6.15. This value is within the healthy range. It has increased from 4.88 (Mar 24) to 6.15, marking an increase of 1.27.
• For PBIT / Share (Rs.), as of Mar 25, the value is 4.43. This value is within the healthy range. It has increased from 3.52 (Mar 24) to 4.43, marking an increase of 0.91.
• For PBT / Share (Rs.), as of Mar 25, the value is 4.34. This value is within the healthy range. It has increased from 3.40 (Mar 24) to 4.34, marking an increase of 0.94.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 3.54. This value is within the healthy range. It has increased from 2.92 (Mar 24) to 3.54, marking an increase of 0.62.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.40. This value is within the healthy range. It has increased from 2.84 (Mar 24) to 3.40, marking an increase of 0.56.
• For PBDIT Margin (%), as of Mar 25, the value is 23.30. This value is within the healthy range. It has increased from 21.73 (Mar 24) to 23.30, marking an increase of 1.57.
• For PBIT Margin (%), as of Mar 25, the value is 16.80. This value is within the healthy range. It has increased from 15.68 (Mar 24) to 16.80, marking an increase of 1.12.
• For PBT Margin (%), as of Mar 25, the value is 16.47. This value is within the healthy range. It has increased from 15.12 (Mar 24) to 16.47, marking an increase of 1.35.
• For Net Profit Margin (%), as of Mar 25, the value is 13.42. This value exceeds the healthy maximum of 10. It has increased from 13.01 (Mar 24) to 13.42, marking an increase of 0.41.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.89. This value is within the healthy range. It has increased from 12.64 (Mar 24) to 12.89, marking an increase of 0.25.
• For Return on Networth / Equity (%), as of Mar 25, the value is 4.27. This value is below the healthy minimum of 15. It has increased from 3.71 (Mar 24) to 4.27, marking an increase of 0.56.
• For Return on Capital Employeed (%), as of Mar 25, the value is 5.49. This value is below the healthy minimum of 10. It has increased from 4.53 (Mar 24) to 5.49, marking an increase of 0.96.
• For Return On Assets (%), as of Mar 25, the value is 3.83. This value is below the healthy minimum of 5. It has increased from 3.29 (Mar 24) to 3.83, marking an increase of 0.54.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.30. It has increased from 0.26 (Mar 24) to 0.30, marking an increase of 0.04.
• For Current Ratio (X), as of Mar 25, the value is 7.83. This value exceeds the healthy maximum of 3. It has increased from 7.16 (Mar 24) to 7.83, marking an increase of 0.67.
• For Quick Ratio (X), as of Mar 25, the value is 7.82. This value exceeds the healthy maximum of 2. It has increased from 7.15 (Mar 24) to 7.82, marking an increase of 0.67.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 338.94. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 338.94, marking an increase of 338.94.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 22.00. This value is within the healthy range. It has increased from 17.57 (Mar 24) to 22.00, marking an increase of 4.43.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 14.63. This value is below the healthy minimum of 20. It has increased from 11.89 (Mar 24) to 14.63, marking an increase of 2.74.
• For Earning Retention Ratio (%), as of Mar 25, the value is 78.00. This value exceeds the healthy maximum of 70. It has decreased from 82.43 (Mar 24) to 78.00, marking a decrease of 4.43.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 85.37. This value exceeds the healthy maximum of 70. It has decreased from 88.11 (Mar 24) to 85.37, marking a decrease of 2.74.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 89.51. This value is within the healthy range. It has increased from 46.81 (Mar 24) to 89.51, marking an increase of 42.70.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 54.45. This value is within the healthy range. It has increased from 29.53 (Mar 24) to 54.45, marking an increase of 24.92.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,610.18. It has increased from 1,331.27 (Mar 24) to 1,610.18, marking an increase of 278.91.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.50. This value exceeds the healthy maximum of 3. It has increased from 4.39 (Mar 24) to 4.50, marking an increase of 0.11.
• For EV / EBITDA (X), as of Mar 25, the value is 19.32. This value exceeds the healthy maximum of 15. It has decreased from 20.18 (Mar 24) to 19.32, marking a decrease of 0.86.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.64. This value exceeds the healthy maximum of 3. It has decreased from 4.70 (Mar 24) to 4.64, marking a decrease of 0.06.
• For Retention Ratios (%), as of Mar 25, the value is 77.99. This value exceeds the healthy maximum of 70. It has decreased from 82.42 (Mar 24) to 77.99, marking a decrease of 4.43.
• For Price / BV (X), as of Mar 25, the value is 1.54. This value is within the healthy range. It has increased from 1.38 (Mar 24) to 1.54, marking an increase of 0.16.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.64. This value exceeds the healthy maximum of 3. It has decreased from 4.70 (Mar 24) to 4.64, marking a decrease of 0.06.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness